Compare CMPX & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPX | AIV |
|---|---|---|
| Founded | 2014 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.5M | 837.1M |
| IPO Year | 2020 | 1996 |
| Metric | CMPX | AIV |
|---|---|---|
| Price | $1.94 | $4.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $15.83 | $10.00 |
| AVG Volume (30 Days) | ★ 7.9M | 1.4M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 87.00% |
| EPS Growth | N/A | ★ 616.00 |
| EPS | N/A | ★ 3.87 |
| Revenue | N/A | ★ $138,486,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $934.41 | N/A |
| P/E Ratio | ★ N/A | $1.10 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.61 | $3.94 |
| 52 Week High | $6.88 | $8.87 |
| Indicator | CMPX | AIV |
|---|---|---|
| Relative Strength Index (RSI) | 19.32 | 50.80 |
| Support Level | N/A | $4.03 |
| Resistance Level | $3.74 | $4.28 |
| Average True Range (ATR) | 0.52 | 0.06 |
| MACD | -0.27 | 0.05 |
| Stochastic Oscillator | 1.91 | 87.40 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.